Clearmind Medicine | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Clearmind Medicine | EFFECT: Others
Clearmind Medicine | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Clearmind Medicine | 6-K: Report of foreign private issuer (related to financial reporting)
Clearmind Medicine | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Clearmind Medicine | EFFECT: Others
Clearmind Medicine | CORRESP: CORRESP
Clearmind Medicine | UPLOAD: Others
Clearmind Medicine | SC 13G: Statement of acquisition of beneficial ownership by individuals-AdvisorShares Trust(5.48%)
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Clearmind Medicine | D: Filing D
Clearmind Medicine | F-1: Registration statement for securities of certain foreign private issuers
Clearmind Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data